True Wealth Design’s Greenwich LifeSciences GLSI Stock Holding History

True Wealth Design’s Portfolio GLSI Stock Details GLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2	Closed	-$20	–	2673
2025 Q1	$20	Buy	+2	New	+$24	﹤0.01%	2583

Other funds holding GLSI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

STRS Ohio Columbus, Ohio $25.2B AUM 30.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

True Wealth Design's GLSI Position: Q2 2025 in Review

True Wealth Design sold out of Greenwich LifeSciences (GLSI) in Q2 2025, closing a stake of 2 shares — an estimated $20 sold.

True Wealth Design first reported a position in GLSI in Q1 2025 and held it in 1 quarter. The position peaked at $20 in Q1 2025. 51 funds tracked by Wall St. Rank hold GLSI as of Q2 2025.

True Wealth Design reported no remaining Greenwich LifeSciences position as of Q2 2025 after selling out during the quarter.
True Wealth Design sold 2 Greenwich LifeSciences shares in Q2 2025, an estimated $20.
True Wealth Design first reported a position in Greenwich LifeSciences in Q1 2025 and held it in 1 quarter.
True Wealth Design's Greenwich LifeSciences position peaked at $20 in Q1 2025.
51 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2025.

Based on True Wealth Design's 13F filing for Q2 2025, filed 6 Aug 2025.